Platform
Features
0 followers
Follow
Facile Therapeutics is bringing Ebselen into the clinic to demonstrate it will be effective in preventing the recurrence of CDI in a Proof-of-Concept (PoC) clinical trial.
Industries
Headquarters
Employees
Links
Marc Navre
8 members
3 members
Verily Life Sciences
38 followers
Alexion Pharmaceuticals
35 followers
GRAIL
27 followers
AGC Biologics
4 followers
Curative
Merck
229 followers
Seres Therapeutics
3 followers
Molecular Devices
2 followers
VIVEX Biologics
Scholar Rock
1 follower
Puma Biotechnology
Explore companies